Home › NDC Lookup › Ingredients › Ganirelix Acetate
📦 NDC / package directory — not a drug information page

Ganirelix Acetate NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Ganirelix Acetate products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

16
Package NDCs
15
Products
15
Active listings
0
Discontinued
15
Labelers
3
Strengths
3
Dosage forms
8
With NADAC pricing

By strength, form & labeler

NDC products by strength
GANIRELIX ACETATE 250 ug/.5mL 10
GANIRELIX ACETATE 1 kg/kg 3
GANIRELIX ACETATE 1 g/g 2
By dosage form
INJECTION, SOLUTION 7
POWDER 5
INJECTION 3
Top labelers
Amphastar Pharmaceuticals, Inc. 1
APICORE PHARMACEUTICALS PRIVATE LI... 1
Aspen Oss B.V. 1
Aurobindo Pharma Limited 1
Chengdu Shengnuo Biopharm Co. Ltd. 1
Ferring Pharmaceuticals Inc. 1
Fresenius Kabi USA, LLC 1
Gland Pharma Limited 1

Browse records — 15 products

Drug / product Billing NDC NADAC / unit Status
Fyremadel ganirelix acetate 250 ug/.5mL INJECTION, SOLUTION Ferring · NDC 55566-1010-01 · 1 BLISTER PACK in 1 CARTON (55566-1010-1) / 1 SYRINGE in 1 BLISTER PACK / .5 mL in 1 SYRINGE 55566-1010-01 $62.347 /unit · NADAC On market View →
Ganirelix Acetate 250 ug/.5mL INJECTION Amphastar · NDC 00548-5001-00 · 1 SYRINGE in 1 CARTON (0548-5001-00) / .5 mL in 1 SYRINGE 00548-5001-00 $62.347 /unit · NADAC On market View →
GANIRELIX ACETATE 250 ug/.5mL INJECTION, SOLUTION Gland · NDC 68083-0472-01 · 1 BLISTER PACK in 1 CARTON (68083-472-01) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS 68083-0472-01 — On market View →
Ganirelix Acetate 250 ug/.5mL INJECTION, SOLUTION Mullan · NDC 83301-0082-01 · 1 SYRINGE, GLASS in 1 CARTON (83301-0082-1) / .5 mL in 1 SYRINGE, GLASS 83301-0082-01 $62.347 /unit · NADAC On market View →
GANIRELIX ACETATE 1 kg/kg POWDER APICORE · NDC 42973-0325-00 · 50 kg in 1 DRUM (42973-325-00) 42973-0325-00 — On market View →
Ganirelix Acetate 1 kg/kg POWDER Aurobindo · NDC 59651-0592-37 · 1 kg in 1 BOTTLE, GLASS (59651-592-37) 59651-0592-37 — On market View →
Ganirelix Acetate 250 ug/.5mL INJECTION Xiromed · NDC 70700-0327-98 · 1 SYRINGE, GLASS in 1 CARTON (70700-327-98) / 1 mL in 1 SYRINGE, GLASS 70700-0327-98 $62.347 /unit · NADAC On market View →
Ganirelix Acetate 250 ug/.5mL INJECTION, SOLUTION Meitheal · NDC 71288-0554-80 · 1 BLISTER PACK in 1 CARTON (71288-554-80) / 1 SYRINGE, GLASS in 1 BLISTER PACK / .5 mL in 1 SYRINGE, GLASS 71288-0554-80 $62.347 /unit · NADAC On market View →
Ganirelix Acetate 250 ug/.5mL INJECTION, SOLUTION Qilu · NDC 67184-0574-01 · 1 BLISTER PACK in 1 CARTON (67184-0574-1) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS 67184-0574-01 — On market View →
Ganirelix Acetate 250 ug/.5mL INJECTION, SOLUTION Lupin · NDC 70748-0274-01 · 1 TRAY in 1 CARTON (70748-274-01) / 1 SYRINGE, GLASS in 1 TRAY / 1 mL in 1 SYRINGE, GLASS 70748-0274-01 $62.347 /unit · NADAC On market View →
Ganirelix Acetate 250 ug/.5mL INJECTION, SOLUTION Organon · NDC 78206-0138-01 · 1 BLISTER PACK in 1 CARTON (78206-138-01) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS 78206-0138-01 — On market View →
Ganirelix Acetate 1 kg/kg POWDER Chengdu · NDC 32861-0009-01 · 1 kg in 1 BOTTLE (32861-0009-1) 32861-0009-01 — On market View →
Ganirelix Acetate 1 g/g POWDER Aspen · NDC 60870-0476-00 · 30 g in 1 BOTTLE, GLASS (60870-0476-0) 60870-0476-00 — On market View →
Ganirelix Acetate 1 g/g POWDER Hybio · NDC 14403-0011-03 · 1 BAG in 1 CANISTER (14403-0011-3) / 100 g in 1 BAG 14403-0011-03 — On market View →
Ganirelix Acetate 250 ug/.5mL INJECTION Fresenius · NDC 65219-0028-05 · 1 SYRINGE, GLASS in 1 CARTON (65219-028-05) / 1 mL in 1 SYRINGE, GLASS 65219-0028-05 $62.347 /unit · NADAC On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.